Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ: SHPH · Real-Time Price · USD
0.3660
-0.0490 (-11.81%)
At close: Apr 11, 2025, 4:00 PM
0.3513
-0.0147 (-4.02%)
After-hours: Apr 11, 2025, 7:59 PM EDT
SHPH Employees
Shuttle Pharmaceuticals Holdings had 9 employees as of December 31, 2024. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$1,016,089
Market Cap
2.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SHPH News
- 1 day ago - Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer - GlobeNewsWire
- 4 weeks ago - Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - GlobeNewsWire
- 4 weeks ago - Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering - GlobeNewsWire
- 4 weeks ago - Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities - GlobeNewsWire
- 6 weeks ago - Shuttle Pharma Provides Corporate Update and Reports 2024 Results - GlobeNewsWire
- 3 months ago - Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - GlobeNewsWire
- 4 months ago - Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient - GlobeNewsWire
- 5 months ago - Shuttle Pharma Provides Third Quarter 2024 Corporate Update - GlobeNewsWire